Title:
新規のSGLT阻害剤
Document Type and Number:
Japanese Patent JP2014517032
Kind Code:
A
Abstract:
The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing one or more conditions or diseases that may be regulated or normalized via inhibition of Sodium Glucose Cotransporter-2 (SGLT-2).
Inventors:
Jane Rajesh
Trehan Sanjay
Das Jagattalan
Nanda Gourmet Cowl
Sunga Sulshi Sustain V. Are S.
Shinni Shan
Sharma Sadir Kumar
Trehan Sanjay
Das Jagattalan
Nanda Gourmet Cowl
Sunga Sulshi Sustain V. Are S.
Shinni Shan
Sharma Sadir Kumar
Application Number:
JP2014515340A
Publication Date:
July 17, 2014
Filing Date:
June 13, 2012
Export Citation:
Assignee:
Panacea Biotech Limited
International Classes:
C07H7/04; A61K31/7034; A61K31/7048; A61K45/00; A61P1/14; A61P3/04; A61P3/06; A61P3/10; A61P3/12; A61P7/10; A61P9/04; A61P9/10; A61P9/12; A61P17/02; A61P19/06; A61P43/00; C07H1/00; C07H9/04
Attorney, Agent or Firm:
Nozomi Watanabe
Haruko Sanwa
Haruko Sanwa